Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-018701
Filing Date
2021-05-07
Accepted
2021-05-07 17:02:45
Documents
1
Period of Report
2021-05-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2407
  Complete submission text file 0000899243-21-018701.txt   4177
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Reporting) CIK: 0000310158 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40235 | Film No.: 21903775
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 (908) 740-4000
Organon & Co. (Issuer) CIK: 0001821825 (see all company filings)

EIN.: 852269702 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations